Norman C. Selby - 14 May 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role: Director
Signature: /s/ Norman Selby
Issuer symbol: N/A
Transactions as of: 14 May 2021
Net transactions value: +$4,600
Form type: 4
Filing time: 18 May 2021, 16:32:04 UTC
Next filing: 11 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INFI	Common Stock	Options Exercise	$4,600	+5,000	+50%	$0.9200^*	15,000	14 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INFI	Stock Option (right to buy)	Options Exercise	$0	-5,000	-12%	$0.000000	35,000	14 May 2021	Common Stock	5,000	$0.9200	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 17, 2020, the Reporting Person was granted 40,000 stock options, 30,000 of which were eligible to vest as long as the holder continued to serve as a director of the issuer and 10,000 of which were eligible to vest as long as the holder continued to serve as Lead Independent Director of the issuer's Board of Directors. The stock options vested over a period of one year in equal quarterly installments beginning at the end of the first calendar quarter after the date of grant. All 40,000 stock options are currently exercisable.

Content

On June 17, 2020, the Reporting Person was granted 40,000 stock options, 30,000 of which were eligible to vest as long as the holder continued to serve as a director of the issuer and 10,000 of which were eligible to vest as long as the holder continued to serve as Lead Independent Director of the issuer's Board of Directors. The stock options vested over a period of one year in equal quarterly installments beginning at the end of the first calendar quarter after the date of grant. All 40,000 stock options are currently exercisable.